Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−447.8x

Market Cap

$647.83M

MomentumView details →

1D Return

+0.00%

YTD Return

+2.83%

RSI (14)

65.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−447.8x

Market Cap

$647.83M

RSI (14)

65.7

MomentumView details →

1D Return

+0.00%

YTD Return

+2.83%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

2.62%

ROA (TTM)

2.53%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+6766.67%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

0.34x

Quick Ratio

0.34x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

13.02M

Op. CF (TTM)

−1.28M

Latest newsMore news →

No recent news for DMII.

Similar companies

Churchill Capital Corp XCCCXU Bain Capital GSS Investment CorBCSS Cantor Equity Partners IV, Inc. Class A Ordinary SharesCEPF Churchill Capital Corp XCCCX Cantor Equity Partners III, Inc. Class A Ordinary SharesCAEP Cartesian Growth Corporation IIICGCT Find similar companies →

Latest newsMore news →

No recent news for DMII.